ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OGN vs IRON // EV/EBITDA & P/E VALUATION

Organon & Co. (NYSE) VS. Disc Medicine Inc. (NASDAQ) • 15-METRIC TALLY: OGN 8 — IRON 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OGN VS. IRON) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OGN IRON SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 53.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 24.90% -27.50% +52.40 OGN /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield 14.83% -4.93% +19.76 OGN /fcf-yield <GO>
Operating Margin — -22.90% — TIE /operating-margins <GO>
Net Profit Margin 3.00% -20.60% +23.60 OGN /net-margins <GO>
Revenue Growth (YoY) -2.90% 16.50% -19.40 IRON /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.43% 0.00% +2.43 OGN /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 26.00 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 5/9 +1.00 OGN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 64.5 62.4 +2.10 OGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.90 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 18.0x 20.0x -2.00 OGN /forward-pe <GO>
Enterprise Scale & Market Cap $3.63B $3.59B $45.8M OGN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OGN REV IRON REV OGN GROSS % IRON GROSS % OGN FCF IRON FCF
FY 2025 $6.22B $0 53.3% — $538.0M -$181.3M
FY 2024 $6.40B $0 58.0% — $764.0M -$94.4M
FY 2023 $6.26B $0 — — $799.0M -$73.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OGN // BETA —
IRON // BETA 0.90